Ann Harris
Acute Care · Brooklyn, NYNPI 1326125907
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,618 of the $13,515 with a category attached, or 63.8%. 17 manufacturers reported payments, led by Boston Scientific at 34.5% of the total. Reporting peaked in 2024 at $5,663 and has fallen 58.9% since, to $2,328 in 2025. Among acute care clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $42.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Impulse Dynamics (USA) Inc.$2K
- Kestra Medical Technology Services, Inc.$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$983
- Medtronic$814
- Biotronik Inc.$761
- plus $3K from 11 others
What the payments were for
- Consulting fees$6885%
- Travel & lodging$4,09030%
- Food & beverage$8,61864%
- Education$1191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 75 | $4,660 |
| Impulse Dynamics (USA) Inc. | 15 | $1,979 |
| Kestra Medical Technology Services, Inc. | 21 | $1,773 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 43 | $983 |
| Medtronic | 60 | $814 |
| Biotronik Inc. | 51 | $761 |
| Abbott | 23 | $702 |
| E.r. Squibb & Sons, L.L.C. | 9 | $699 |
| Scpharmaceuticals Inc. | 8 | $406 |
| Bardy Diagnostics, Inc. | 4 | $350 |
| AstraZeneca | 1 | $120 |
| Cvrx, Inc. | 1 | $104 |
| Cordis US CORP. | 1 | $47 |
| Merck | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Novartis | 1 | $26 |
| Pfizer | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$3,008
- Assure WCD$1,287
- CAMZYOS$500
- CardioMEMS HF System$146
- FARXIGA$120
- LifeVest$119
- FUROSCIX$118
- Barostim Neo System$104
- Carnation Ambulatory Monitor$102
How this compares
$13,515 in reported general payments places this provider in the 95th percentile of 980 acute care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 95 | $90,312 |
| EliquisApixaban | 87 | $87,929 |
| XareltoRivaroxaban | 80 | $77,009 |
| FarxigaDapagliflozin Propanediol | 53 | $49,298 |
| JardianceEmpagliflozin | 18 | $11,825 |
| Dofetilide | 15 | $4,383 |
| Metoprolol Succinate | 73 | $1,366 |
| Warfarin Sodium | 45 | $334 |
| SotalolSotalol Hcl | 20 | $156 |
| Atorvastatin Calcium | 13 | $150 |
| Carvedilol | 29 | $149 |
| Torsemide | 13 | $133 |
| Furosemide | 32 | $79 |
| Rosuvastatin Calcium | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $26 | $90,31295 claims |
| PfizerEliquis | $25 | $87,92987 claims |
| AstraZenecaFarxiga | $120 | $49,29853 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 980 acute care providers in New York.
Other acute care in Brooklyn
- Sun Young GeninBrooklyn$4K
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Marcel RozarioMedina$10K
- Julie Anne RoldanNew York$10K
- Dana SiscoSuffern$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.